MRVI — Maravai LifeSciences Holdings Inc. price, chart and key statistics

Price data

Price

$7.20

YTD price return

+121.54%

YTD total return

+121.54%

Next earnings

Nov 4, 2026 · After close

Market cap

1.9B2020-12 810.9M2026-10 1.9B+130.5% over the window

Enterprise value

2.2B

Shares outstanding

259.6M2019-12 253.9M2026-06 259.6M+2.2% over the window

52W low

$2.55

52W high

$9.42

From 52W high

-23.57%

From 52W low

+182.91%

52W range

68%

Volume

Rel volume

0.77×

30D volume

2.6M

30D $ vol

19M

Fundamentals

Sales (ttm)

208.8M2019-12 143.1M2026-06 208.8M+45.9% over the window

Sales/share

$0.802019-12 $0.562026-06 $0.80+42.7% over the window

EPS (ttm)

-$0.532019-12 -$0.032026-06 -$0.53+1666.2% over the window

FCF (ttm)

-35.8M2019-12 7M2026-06 -35.8M-614.5% over the window

FCF/share

-$0.142019-12 $0.032026-06 -$0.14-603.2% over the window

Book value/share

$0.792019-12 $0.572026-06 $0.79+38.4% over the window

Net margin

-37.07%2019-12 -3.1%2026-06 -37.1%+1087.0% over the window

ROE

-37.82%2019-12 -3.1%2026-06 -37.8%+1123.6% over the window

ROA

-12.82%2020-12 7.0%2026-06 -12.8%-283.1% over the window

Debt / equity

0.71×2020-12 5.972026-06 0.71-88.1% over the window

Current ratio

4.052020-12 2.542026-06 4.05+59.8% over the window

Growth (CAGR, ttm) · 10Y

Sales

-5.03%2025-06-30 → 2026-06-30219.8M → 208.8M (-5.0% total)-27.32%2023-06-30 → 2026-06-30543.9M → 208.8M (-61.6% total)-17.68%2021-06-30 → 2026-06-30552.2M → 208.8M (-62.2% total)n/a

Shares

+1.67%2025-06-30 → 2026-06-30255.3M → 259.6M (+1.7% total)+25.32%2023-06-30 → 2026-06-30131.9M → 259.6M (+96.8% total)+18.25%2021-06-30 → 2026-06-30112.3M → 259.6M (+131.2% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

-6.60%2025-06-30 → 2026-06-30$0.86 → $0.80 (-6.6% total)-42.00%2023-06-30 → 2026-06-30$4.12 → $0.80 (-80.5% total)-30.38%2021-06-30 → 2026-06-30$4.92 → $0.80 (-83.6% total)n/a

Book value/share

-24.32%2025-06-30 → 2026-06-30$1.04 → $0.79 (-24.3% total)-41.54%2023-06-30 → 2026-06-30$3.95 → $0.79 (-80.0% total)-14.52%2021-06-30 → 2026-06-30$1.73 → $0.79 (-54.4% total)n/a

Price

+104.65%2025-10-20 → 2026-10-20$3.52 → $7.20 (+104.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.38%2023-10-20 → 2026-10-20$6.91 → $7.20 (+4.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-29.33%2021-10-20 → 2026-10-20$40.85 → $7.20 (-82.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+104.65%2025-10-20 → 2026-10-20$3.52 → $7.20 (+104.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.38%2023-10-20 → 2026-10-20$6.91 → $7.20 (+4.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-29.33%2021-10-20 → 2026-10-20$40.85 → $7.20 (-82.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-13.6×2020-12 9.112026-10 -24.15-365.0% over the window

P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.

10.2×2020-12 6.762026-10 -15.96-336.1% over the window

Fwd P/E

-69.4×

P/S (ttm)Market cap ÷ TTM revenue.

9.0×2020-12 2.852026-10 8.95+213.6% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

9.1×2020-12 9.162026-10 9.13-0.3% over the window

EV/Sales (ttm)

10.4×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-1.92%2020-12 15.6%2026-06 -2.2%-114.2% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 259.6M ÷ 255.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-1.67%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.67%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($615.3M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-1.67%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2020-12 4.2%2026-06 0.0%-100.0% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.9B). Same caveat as the cash buyback yield.

0.00%2020-12 4.2%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/E

60th

P/OI

50th

P/S

79th

P/B

67th

P/FCF

97th